Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 1.00 |
| ▸ | F2 | P00734 | 1/20 | 0.67 |
| ▸ | PLAT | P00750 | 1/20 | 0.67 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7019543 | 0.91 | F10 (1.00) | F10F2PLATKLKB1 | |
| SCHEMBL7015474 | 0.89 | F10 (1.00) | F10F2PLATKLKB1 | |
| SCHEMBL7021449 | 0.86 | F10 (0.76) | F10F2PLATKLKB1 | |
| SCHEMBL7016709 | 0.81 | F10 (0.77) | F10F2PLATKLKB1 | |
| SCHEMBL7013757 | 0.81 | F10 (1.00) | F10F2PLATKLKB1 | |
| SCHEMBL7019388 | 0.81 | F10 (0.73) | F10F2PLATKLKB1 | |
| Hydrochloric Acid SCHEMBL7020126 | 0.81 | F10 (0.75) | F10F2PLATKLKB1 | |
| SCHEMBL7014175 | 0.80 | F10 (1.00) | F10F2PLATKLKB1 | |
| SCHEMBL7008998 | 0.80 | F10 (0.78) | F10F2PLATKLKB1 | |
| SCHEMBL7018524 | 0.80 | F10 (0.75) | F10F2PLATKLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030187023-A1 | Sulfone derivatives, process for their production and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2003-10-02 | — | — | US | disclosed |
| EP-1302462-A1 | SULFONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2003-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187023-A1 | Sulfone derivatives, process for their production and use thereof | SULT1E1, RRS1, SHH | F10 717/4885F2 685/4885PLAT 4838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.